Document Detail


Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy.
MedLine Citation:
PMID:  7632508     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sixteen children with biopsy-confirmed type I membranoproliferative glomerulonephritis (MPGN) were treated with six alternate-day intravenous pulses of methylprednisolone followed by single-dose alternate-day prednisone for 12-66 months (mean 37 months). The average length of follow-up was 52 months (range 12-127 months). Compared with pretreatment values, the frequency of hematuria (13/16 vs. 8/16, P < 0.05) and the levels of serum albumin (2.66 +/- 0.69 vs. 3.76 +/- 0.39 g/dl, P < 0.001), creatinine clearance (97 +/- 37 vs. 129 +/- 26 ml/min/1.73 m2, P < 0.001), and proteinuria (5.2 +/- 5.1 vs. 1.0 +/- 0.8 g/day, P < 0.001) were significantly improved after 3 months of therapy. Improvement has persisted through the end of the follow-up period. Repeat kidney biopsies showed a significant reduction in acute changes but an increase in chronic changes. Thirteen patients have been off therapy from 1 to 74 months (mean 20.8 months). Nine have a normal urinalysis, creatinine clearance, and protein excretion. The remainder have normal renal function but proteinuria ranging from 3.2 to 4.3 g/day. The data support the evidence of other investigators that corticosteroid therapy is beneficial in type I MPGN and suggest that initiation with pulse methylprednisolone may promote early stabilization of the disease.
Authors:
J M Bergstein; S P Andreoli
Related Documents :
23111008 - The natural history of compensated hcv-related cirrhosis: a prospective long-term study.
7941188 - Loin pain-hematuria syndrome: how effective is renal autotransplantation in its treatment?
24642108 - Does arthroscopic knee surgery work?
24021848 - Lost in the crowd: entitative group membership reduces mind attribution.
8584828 - First selective amygdalohippocampal radiosurgery for 'mesial temporal lobe epilepsy'.
12710758 - Clinical outcome observed in subjects with recurrent periodontal disease following loca...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pediatric nephrology (Berlin, Germany)     Volume:  9     ISSN:  0931-041X     ISO Abbreviation:  Pediatr. Nephrol.     Publication Date:  1995 Jun 
Date Detail:
Created Date:  1995-09-12     Completed Date:  1995-09-12     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8708728     Medline TA:  Pediatr Nephrol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  268-71     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Child
Child, Preschool
Creatinine / blood
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Glomerulonephritis, Membranoproliferative / drug therapy*,  metabolism,  pathology
Humans
Infusions, Intravenous
Male
Methylprednisolone / administration & dosage*
Prednisone / administration & dosage*
Proteinuria / drug therapy
Retrospective Studies
Serum Albumin / metabolism
Treatment Outcome
Chemical
Reg. No./Substance:
0/Serum Albumin; 53-03-2/Prednisone; 60-27-5/Creatinine; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation and management of bilateral renal artery stenosis in children: a case series and review.
Next Document:  Idiopathic membranoproliferative glomerulonephritis in Japanese children.